Literature DB >> 9862429

Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages.

F D'Acquisto1, L Sautebin, T Iuvone, M Di Rosa, R Carnuccio.   

Abstract

We investigated the effect of PGE2 and iloprost (a prostacyclin analogue) on inducible nitric oxide synthase (iNOS) protein expression and nuclear factor-kappaB (NF-kappaB) activation in lipopolysaccharide (LPS)-stimulated J774 macrophages. Incubation of J774 cells with LPS (10 microg/ml) caused an increase of iNOS protein expression which was prevented in a concentration-dependent fashion by PGE2 (0.1, 1, 10 microM) and iloprost (0.01, 0.1, 1 microM). Electrophoretic mobility shift assay indicated that both prostanoids blocked the activation of NF-kappaB, a transcription factor necessary for NO synthase induction. PGE2 and iloprost also blocked disappearance of I kappaB-alpha from cytosolic fraction and nuclear translocation of NF-kappaB subunits p50 and p65. These results show for the first time that PGE2 and iloprost down-regulate iNOS protein expression by inhibiting NF-kappaB activation and suggest a negative feed-back mechanism that may be important for limiting excessive or prolonged NO production in pathological events.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862429     DOI: 10.1016/s0014-5793(98)01407-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

2.  Outsmarting the host: bacteria modulating the immune response.

Authors:  Matthew D Woolard; Jeffrey A Frelinger
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  TFF3 modulates NF-{kappa}B and a novel negative regulatory molecule of NF-{kappa}B in intestinal epithelial cells via a mechanism distinct from TNF-{alpha}.

Authors:  Ya-Qin Zhu; Xiao-Di Tan
Journal:  Am J Physiol Cell Physiol       Date:  2005-07-13       Impact factor: 4.249

4.  Prostaglandin E2 reduces Toll-like receptor 4 expression in alveolar macrophages by inhibition of translation.

Authors:  Angela Juliette Degraaf; Zbigniew Zasłona; Emilie Bourdonnay; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2014-08       Impact factor: 6.914

5.  Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice.

Authors:  Andrey Frolov; Lihua Yang; Hua Dong; Bruce D Hammock; Leslie J Crofford
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-08-30       Impact factor: 4.006

6.  Eicosadienoic acid differentially modulates production of pro-inflammatory modulators in murine macrophages.

Authors:  Yung-Sheng Huang; Wen-Cheng Huang; Chi-Wei Li; Lu-Te Chuang
Journal:  Mol Cell Biochem       Date:  2011-06-19       Impact factor: 3.396

7.  Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages.

Authors:  A Castrillo; M J Díaz-Guerra; S Hortelano; P Martín-Sanz; L Boscá
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis.

Authors:  James C Bonner; Annette B Rice; Jennifer L Ingram; Cindy R Moomaw; Abraham Nyska; Alyce Bradbury; Alisha R Sessoms; Patricia C Chulada; Daniel L Morgan; Darryl C Zeldin; Robert Langenbach
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation.

Authors:  Manabu Minami; Koichi Shimizu; Yoshihisa Okamoto; Eduardo Folco; Marco-Lopez Ilasaca; Mark W Feinberg; Masanori Aikawa; Peter Libby
Journal:  J Biol Chem       Date:  2008-02-12       Impact factor: 5.157

10.  Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis.

Authors:  William Walker; Dino Rotondo
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.